IP Library Granted Patent US 8,053,213
Granted Patent B2
US 8,053,213 · App. 12/876,320 · Granted Nov 8, 2011

Detection of PCR products in gel electrophoresis

Assignee: Roche Diagnostics Operations, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,053,213
App. No.
12/876,320
Granted
Nov 8, 2011
Kind
B2
Abstract

Disclosed is a method for analyzing nucleic acids in a sample comprising the following steps: (i) adding a DNA binding dye containing a benzothiazolium or benzoxazolium group to the sample to be analyzed, (ii) carrying out a polymerase chain reaction, (iii) applying the sample to a gel matrix, (iv) separating the nucleic acid molecules according to their size by applying a voltage and (v) excitation with light of a suitable wavelength for the optical visualization of the nucleic acid/DNA binding dye complexes.

Claims (17)

1. A method for analyzing nucleic acids in a sample containing DNA comprising the steps of

adding a DNA binding dye to the sample to bind the nucleic acids in the sample and form a nucleic acid/DNA binding dye complex, wherein the DNA binding dye is RO 27 having a structure:

amplifying the nucleic acids by means of a polymerase chain reaction (PCR),

applying the amplified sample to a gel matrix,

separating the amplified nucleic acid molecules according to size by applying a voltage to the gel matrix,

exciting the molecules with light at a wavelength suitable for visualizing the dye complex, and

optically visualizating the nucleic acid/DNA binding dye complex, thereby analyzing the nucleic acids in the sample,

wherein the gel matrix is not pre-stained prior to separating the nucleic acid molecules and wherein the gel matrix is not stained after separating the nucleic acid molecules.

2. The method according to claim 1 wherein the amplification is measured in real time during the PCR with the aid of the DNA binding dye.

3. The method according to claim 1 wherein the gel matrix is polyacrylamide or agarose.

4. The method according to claim 3 wherein the gel matrix is polyacrylamide and is present in a capillary.

5. The method according to claim 1 wherein the DNA binding dye is added to the sample at a concentration of 1-10 μM.

6. The method according to claim 1 wherein the DNA binding dye is added to the sample at a concentration of 2-4 μM.

7. A kit for carrying out the method of claim 1 comprising

reagents for carrying out a polymerase chain reaction,

a vessel containing RO 27, and

at least one polyacrylamide gel matrix.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2010
From: BIRKNER, CHRISTIAN
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 025032/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2010
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 025032/0397 →
Priority Claims (1)
EP 08006994 · Apr 8, 2008 · regional
Continuity (2)
Continuation PCTEP2009002264 · Mar 27, 2009
Related Publication 20100330579A1 · Dec 30, 2010